Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ANGLOGOLD ASHANTI PLC (AU)

  • Business News
  • March 26, 2026, 10:30 UTC
  • 1
  • 1 comments

AngloGold Ashanti Publishes Its 2025 UK Annual Report, Form 20-F, Other Annual Reports and 2026 AGM Notice

Market reaction Comment Full text

OPC ENERGY LTD (OPCE)

  • Business News
  • March 26, 2026, 10:23 UTC
  • 1
  • 1 comments

Register of shareholders, changes and capital status

Market reaction Comment Full text

COMSTOCK INC. (LODE)

  • Business News
  • March 26, 2026, 10:15 UTC
  • 1
  • 1 comments

Comstock Inc. Announces 2026 Annual Meeting

Market reaction Comment Full text

QS ENERGY, INC. (QSEP)

  • Business News
  • March 26, 2026, 10:12 UTC
  • 0
  • 1 comments

Net Asset Value(s)

Market reaction Comment Full text

SHOE CARNIVAL INC (SCVL)

  • Business News
  • March 26, 2026, 10:10 UTC
  • 1
  • 1 comments

Shoe Carnival Reports Fourth Quarter and Fiscal 2025 Results; Provides Fiscal 2026 Guidance

Market reaction Comment Full text

SIGNATURE DEVICES, INC. (SDVI)

  • Business News
  • March 26, 2026, 10:06 UTC
  • 3
  • 1 comments

Net Asset Value(s)

Market reaction Comment Full text

ORACLE CORP (ORCL)

  • Business News
  • March 26, 2026, 10:05 UTC
  • 3
  • 1 comments

INVESTOR DEADLINE: Oracle Corporation (ORCL) Investors with Substantial Losses Have Opportunity to Lead the Oracle Class Action Lawsuit

Market reaction Comment Full text

Rockwell Medical Inc. (RMTI)

  • Business News
  • March 26, 2026, 10:00 UTC
  • 4
  • 1 comments

Rockwell Medical Announces Fourth Quarter and Full-Year 2025 Financial and Operational Results

Market reaction Comment Full text

INTERNATIONAL BUSINESS MACHINES CORP (IBM)

  • Business News
  • March 26, 2026, 10:00 UTC
  • 3
  • 1 comments

IBM Quantum Computer Accurately Simulates Real Magnetic Materials, Reproducing National Laboratory Data

Market reaction Comment Full text

Kodiak Sciences Inc (KOD)

  • Business News
  • March 26, 2026, 10:00 UTC
  • 3
  • 1 comments

Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham

Market reaction Comment Full text
  • Previous
  • 442
  • 443
  • 444
  • 445
  • 446
  • Next

Search

News categories

  • Technical Exchange News(11639)
  • Event(3907)
  • SEC News(228356)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(140741)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin